Garba I H, Ubom G A
Industrial Chemistry Programme, Abubakar Tafawa Balewa University, PMB 0248, Bauchi, Nigeria.
Singapore Med J. 2005 Nov;46(11):632-4.
Lactate dehydrogenase (LDH) activity was assayed in the sera of 76 adult male and 76 adult female patients within the age group of 18-40 years presenting with acute, uncomplicated Plasmodium falciparum malaria infection and a control group of 80 healthy adults within the same age group.
Patient selection and pre-qualification were done by simple random sampling of individuals presenting at the Bauchi Specialist Hospital Outpatient Department with a history of fever and malaise within a period of one to eight days, and who were confirmed to be infected with the P. falciparum malaria parasite by microscopical examination of Giemsa-stained thin blood slides.
The mean serum LDH activity in male patients was found to be 789.4 +/- 35.0 IU. This activity is significantly higher than the control LDH activity of 247.10 +/- 19.0 IU (p-value is less than 0.05). The mean serum LDH activity among female patients was 634.0 +/- 35.0 IU, which is a relatively higher activity compared to the control LDH activity of 247.10 +/- 19.0 IU (p-value is less than 0.05).
The combination of acute hepatocellular injury and red cell haemolysis induced by the invading merozoites may account for the increase in serum LDH activity during this infection. Therefore serum LDH activity is a potentially valuable enzymatic marker of acute, uncomplicated P. falciparum malaria infection, especially in the absence of other complicating diseases known to be associated with the above normal serum LDH activities.
对76名年龄在18至40岁之间、患有急性非复杂性恶性疟原虫疟疾感染的成年男性患者和76名成年女性患者,以及80名同一年龄组的健康成年人对照组的血清进行了乳酸脱氢酶(LDH)活性检测。
通过简单随机抽样选取在包奇专科医院门诊部就诊、有1至8天发热和不适病史、经吉姆萨染色薄血涂片显微镜检查确诊感染恶性疟原虫的个体进行患者选择和资格预审。
发现男性患者的平均血清LDH活性为789.4±35.0国际单位。该活性显著高于对照组的LDH活性247.10±19.0国际单位(p值小于0.05)。女性患者的平均血清LDH活性为634.0±35.0国际单位,与对照组的LDH活性247.10±19.0国际单位相比相对较高(p值小于0.05)。
侵入的裂殖子诱导的急性肝细胞损伤和红细胞溶血可能是导致此次感染期间血清LDH活性升高的原因。因此,血清LDH活性是急性非复杂性恶性疟原虫疟疾感染的潜在有价值的酶学标志物,尤其是在没有其他已知与上述血清LDH活性升高相关的并发疾病的情况下。